Now Trending: Fall Vaccine Hesitancy, AI in Respiratory Care
Drug Topics
SEPTEMBER 21, 2024
Check out this recap of articles published on our sister sites during the past week.
Sat.Sep 21, 2024
185 
NCPA Continues Push for Congressional PBM, Health Care Reform
Pharmacy Times
SEPTEMBER 21, 2024
As the end of this Congress approaches, the National Community Pharmacists Association is lobbying members to pass pharmacy benefit manager reforms.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Small Doses: September 16 to September 20
Drug Topics
SEPTEMBER 21, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Opinion: First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
STAT
SEPTEMBER 21, 2024
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
A Look Into Bioprocessing Innovations for Downstream Processing Efficiencies (BIO 2024)
BioPharm
SEPTEMBER 21, 2024
Ecolab's Hayley Crowe, executive vice-president and general manager Global Life Sciences sat down at BIO 2024 to discuss technology innovations and how they have enhanced downstream bioprocessing.
Australian demand for overdose drug naloxone more than doubles after spike in synthetic opioid deaths
The Guardian - Pharmaceutical Industry
SEPTEMBER 21, 2024
Take Home Naloxone program, which allows access without a prescription, sees rise in use after multiple reports of people who unknowingly used laced drugs and died Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast Demand for a life-saving opioid overdose drug has doubled in one year as a “whole new cohort” of stimulant and hallucinogenic users, fearful of taking lethally laced narcotics, have rushed to get the medication.
Let's personalize your content